Day April 1, 2026
HMN 2026: How Trace levels of food pathogen do not always translate to health risk,
HMN 2026: How Food fortification already prevents 7 billion nutrient gaps annually, but we could triple its impact
HMN 2026: What is Flumist, the new flu vaccine for kids that’s sprayed in their noses?
HMN 2026: How New ‘fishhook’ bonds help T cells stick longer to prostate cancer cells
HMN 2026: How Hearing yourself speak helps fine-tune tongue movements
HMN 2026: How Financial decline is linked to faster memory aging in older adults
Worse financial well-being in midlife and older age—and especially declines over time—are associated with lower memory scores and faster cognitive decline, reports a new study at Columbia University Mailman School of Public Health. The population experiencing significant financial deterioration showed…
HMN 2026: How Fiber in whole wheat foods protects against gut inflammation in mice,
HMN 2026: How FGFR1 boosts cholesterol uptake in prostate cancer cells
HMN 2026: How Well-fed penguins live longer but age faster—much like modern humans
HMN 2026: How FDA should consider redesign of proposed nutrition labels
HMN 2026: What is the gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder
HMN 2026: How FDA-approved fatty liver drug also suppresses liver tumors in mice
HMN 2026: How FDA-approved compound promotes neuroprotective effects in Parkinson’s disease
NALL improves dopamine-dependent motor learning impairments in LRRK2R1441C mice. Credit: Journal of Clinical Investigation (2026). DOI: 10.1172/jci196137 Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson’s disease. The compound, N-acetyl-L-leucine (NALL), simultaneously…
